文献速递眼底病与葡萄膜炎

实验性自身免疫性葡萄膜炎期间肠道稳态与肠道菌群的破坏

Disruption of Intestinal Homeostasis and Intestinal Microbiota During Experimental Autoimmune Uveitis.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2019-01-01

该研究在B10.RIII小鼠中用IRBP肽与MTB佐剂诱导EAU,通过16S rRNA测序等发现葡萄膜炎早期即出现肠道通透性增加、抗菌肽表达升高和菌群改变,且部分变化为葡萄膜炎动物特有。结论认为自身免疫性葡萄膜炎伴随肠道菌群失调与肠道稳态破坏,提示新的治疗靶轴。

要点

  • EAU早期即出现肠道通透性增加和抗菌肽表达升高,早于眼部炎症高峰。
  • 肠道通透性在2周达峰,与菌群差异、脂质运载蛋白产生及葡萄膜炎高峰同步。
  • 部分肠道菌群变化为葡萄膜炎动物特有,部分仅由MTB佐剂影响。

核心结论

  • 自身免疫性葡萄膜炎伴随肠道菌群失调和肠道稳态破坏,但MTB佐剂单独也可促进肠道破坏。

研究设计与样本

  • 在B10.RIII小鼠中联用IRBP肽与灭活分枝杆菌抗原(MTB)佐剂诱导实验性自身免疫性葡萄膜炎(EAU)。
  • 采用16S rRNA基因测序分析葡萄膜炎病程中肠道菌群差异,并评估肠道形态、FITC-葡聚糖渗漏、胃肠道抗菌肽表达及T淋巴细胞比例。

主要发现

  • 葡萄膜炎早期、炎症高峰前,肠道通透性增加和肠道抗菌肽表达升高与肠系膜淋巴结效应T细胞增多在时间上重合。
  • 肠道形态变化在该阶段最显著,但单独MTB佐剂也可引起;肠道通透性增加仅见于发生葡萄膜炎的IRBP免疫小鼠。
  • 葡萄膜炎病程中肠道菌群发生改变,部分变化为葡萄膜炎动物特有,部分受MTB佐剂单独影响。
  • 肠道通透性在2周达峰,与肠道菌株差异增加、脂质运载蛋白产生峰值及葡萄膜炎高峰同步。

临床怎么用

  • 提示监测自身免疫性葡萄膜炎患者的肠道屏障功能与菌群状态可能具有临床意义。
  • 肠道菌群与肠道稳态轴或可作为未来实验或临床治疗靶点,但尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We determine the changes in intestinal microbiota and/or disruptions in intestinal homeostasis during uveitis. METHODS: Experimental autoimmune uveitis (EAU) was induced in B10.RIII mice with coadministration of interphotoreceptor retinoid-binding protein peptide (IRBP) and killed mycobacterial antigen (MTB) as an adjuvant. Using 16S rRNA gene sequencing, we looked at intestinal microbial differences during the course of uveitis, as well as intestinal morphologic changes, changes in intestinal permeability by FITC-dextran leakage, antimicrobial peptide expression in the gastrointstinal tract, and T lymphocyte prevalence before and at peak intraocular inflammation. RESULTS: We demonstrate that increased intestinal permeability and antimicrobial peptide expression in the intestinal tract coincide in timing with increased effector T cells in the mesenteric lymph nodes, during the early stages of uveitis, before peak inflammation. Morphologic changes in the intestine were most prominent during this phase, but also occurred with adjuvant MTB alone, whereas increased intestinal permeability was found only in IRBP-immunized mice that develop uveitis. We also demonstrate that the intestinal microbiota were altered during the course of uveitis, and that some of these changes are specific to uveitic animals, whereas others are influenced by adjuvant MTB alone. Intestinal permeability peaked at 2 weeks, coincident with an increase in intestinal bacterial strain differences, peak lipocalin production, and peak uveitis. CONCLUSIONS: An intestinal dysbiosis accompanies a disruption in intestinal homeostasis in autoimmune uveitis, although adjuvant MTB alone promotes intestinal disruption as well. This may indicate a novel axis for future therapeutic targeting experimentally or clinically.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Janowitz C, Nakamura YK, Metea C, et al. Disruption of Intestinal Homeostasis and Intestinal Microbiota During Experimental Autoimmune Uveitis. Invest Ophthalmol Vis Sci. 2019. PMID: 30695094. doi:10.1167/iovs.18-24813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。